Early improvement predicted the treatment response to SSRIs at 12 weeks (P<0.001) in patients with MDD, whereas early non-improvement in insomnia and anxiety was associated with a poor response (OR =9.487; 1.312–68.588 and OR =12.947; 1.99–82.246) https